Skip to main content

Table 2 Demographics of cohort at baseline stratified by TREM2 variant carriership

From: TREM2 risk variants and associated endophenotypes in alzheimer’s disease

  

Main analysis

  

Exploratory analysis

 
     

TREM2 variant carriers

 

Total

Non-carriers

All TREM2 carriers

p-value

R62H

R47H

T96K

Otherd

Total

1582 (100)

1459 (92)

123 (8)

 

66 (4)

26 (2)

16 (1)

17 (1)

AD-dementia

1364 (86)

1263 (87)

101 (82)

0.215

53 (80)

23 (88)

15 (94)

12 (71)

MCI-AD

218 (14)

196 (13)

22 (18)

13 (20)

3 (12)

1 (6)

5 (29)

Female

824 (52)

757 (52)

67 (54)

0.647

36 (55)

11 (42)

12 (75)

9 (53)

Education, median (IQR)

1 (0–2)

1 (0–2)

1 (0–2)

0.697

1 (0–2)

1 (0–2)

1 (0.75–1)

1 (0–2)

Positive family historya,e

691 (46)

623 (45)

68 (57)

0.021*

35 (53)

15 (62)

9 (56)

11 (69)

ApoE-ε4 carrierb

1076 (69)

990 (69)

86 (71)

0.708

47 (72)

16 (62)

13 (87)

11 (65)

Age at diagnosis, mean ± SD

64.4 ± 7.0

64.4 ± 7.0

64.4 ± 7.1

0.924

65.2 ± 6.5

64.6 ± 9

61.4 ± 6.7

64.4 ± 5.8

Died

949 (60)

878 (60)

71 (58)

0.662

35 (53)

22 (85)

7 (44)

8 (47)

Age at deathc, mean ± SD

71 ± 7.7

71.1 ± 7.7

70.4 ± 7.9

0.496

70.4 ± 6.8

70.5 ± 9.7

69.9 ± 9.7

71.7 ± 6.5

  1. Table shows n (%) unless otherwise specified. TREM2 variant carriers and non-carriers were compared with Chi-squared tests for categorical variables, and with t-tests for continuous variables
  2. * p-value < 0.05
  3. Total n: a = 1497, b = 1556, c = 948; d = Other TREM2 variants include: D87N, G58A, Q33X, C51Y, R47G, S31F, and A105V; e = Positive family history, i.e. affected first-degree relative
  4. Abbreviations AD Alzheimer’s Disease, ApoE-ε4 Apolipoprotein E ε4, IQR Interquartile Range, MCI Mild Cognitive Impairment, NA Not Available, R47H p.Arg47His, R62H p.Arg62His, T96K p.Thr96Lysm SD Standard Deviation, TREM2 Triggering Receptor Expressed on Myeloid Cells 2